Summary
- GLP-1 receptor agonists are highly effective medications for weight loss, originally developed for type 2 diabetes
- Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved specifically for weight management
- Clinical trials show average weight loss ranging from 15-22% of body weight
- These medications work by reducing appetite, slowing digestion, and improving blood sugar control
- Choice depends on individual factors including insurance coverage, side effects, and weight loss goals
- All GLP-1 medications require a prescription and medical supervision
GLP-1 receptor agonists have revolutionized weight loss treatment, offering hope to millions struggling with obesity. These medications, which mimic a natural hormone that regulates appetite and blood sugar, have demonstrated remarkable effectiveness in clinical trials and real-world use.